Parkinsons

GLP-1 Agonists Show Mixed Neurology Trial Evidence Despite Strong Mechanisms

July 3, 2026 by BrainASAP

TL;DR: A 2026 review in Drug Design, Development and Therapy argued that glucagon-like peptide-1 (GLP-1) receptor agonists, drugs that mimic a metabolic hormone involved in glucose control, have credible brain-protection mechanisms, but clinical evidence for neurological disorders remains mixed. Key Findings 15-page review: Li et al. summarized GLP-1 receptor agonist mechanisms and evidence across neurodegenerative, …

TMEV Virus Created Parkinson’s-Like Dopamine Neuron Loss in Mice

July 1, 2026 by BrainASAP

TL;DR: A 2026 study in Brain, Behavior, & Immunity – Health reported that Theiler’s murine encephalomyelitis virus (TMEV), a mouse neurotropic virus, infected substantia nigra dopamine neurons and produced Parkinson’s-like motor deficits in mice. Key Findings 13 TMEV mice vs 14 controls: The main behavioral experiment compared unilateral TMEV injection into the substantia nigra with …

Parkinson’s Prevention Review Highlights Exercise, Diet, Toxins, and Rehabilitation

June 30, 2026 by BrainASAP

TL;DR: A 2026 narrative review in Neurological Research and Practice argued that Parkinson’s prevention is most actionable through physical activity, Mediterranean-style diet patterns, toxin reduction, earlier prodromal detection, and better rehabilitation after diagnosis. Key Findings Fastest-growing neurological disorder: The review described Parkinson’s disease as the fastest-growing neurological disorder worldwide. 6.2 to 11.8 million cases: A …

AI-Guided Variable Levodopa Feasible in 5 Parkinson’s Patients

June 30, 2026 by BrainASAP

TL;DR: A 2026 open-label feasibility trial in IBRO Neuroscience Reports tested an AI-guided variable levodopa schedule in 5 people with Parkinson’s disease and found 4 patients improved on UPDRS, but the study was far too small and uncontrolled to prove efficacy. Key Findings Feasibility sample: The single-center trial enrolled 5 people with Parkinson’s disease after …

AI Remote Monitoring Studies Favored Parkinson’s but Had High Bias Risk

June 27, 2026 by BrainASAP

TL;DR: A 2026 systematic review in BMC Medical Informatics and Decision Making found that AI models using remote-monitoring data were most often studied in Parkinson’s disease, but 56 of 76 prospective studies had high risk of bias. Key Findings 6,668 records were screened: Researchers narrowed the search to 76 prospective studies of machine learning for …

Rotenone Parkinson’s Fly Model Showed Sex-Specific Gene Responses

June 24, 2026 by BrainASAP

TL;DR: A 2026 fly study in IBRO Neuroscience Reports found that long-term rotenone exposure produced stronger survival, climbing, oxidative-stress, and late immune-gene disruption in male Drosophila than in female flies. Key Findings 90 flies per sex were tracked: Survival assays used three sets of 30 male or female flies after rotenone feeding. Two disease windows …

Human Substantia Nigra Neurons Reflected Recent Reward History

June 23, 2026 by BrainASAP

TL;DR: A 2026 iScience study recorded human substantia nigra neurons during Parkinson’s surgery and found that putative dopamine-neuron firing was higher after a prior reward, while the next response was modestly faster. Key Findings Direct human recordings: Researchers recorded 27 substantia nigra neurons across 13 sessions in 11 Parkinson’s disease patients undergoing deep-brain stimulation surgery. …

REDDI MEG AI Classified Four Neurodegenerative Diseases With 0.81 Balanced Accuracy

June 22, 2026 by BrainASAP

TL;DR: A 2026 preprint in medRxiv reported that REDDI, an interpretable AI pipeline using resting-state magnetoencephalography (MEG), classified four neurodegenerative diseases with mean balanced accuracy of 0.81. Key Findings The dataset covered four disease groups: it included 32 people with mild cognitive impairment, 18 with multiple sclerosis, 20 with Parkinson’s disease, and 39 with amyotrophic …

Il6 Deficiency Worsened Parkinson’s Mouse Damage by Sex

June 18, 2026 by BrainASAP

TL;DR: A 2026 study in Genes & Diseases found that Il6 deficiency, meaning loss of the gene for interleukin-6, worsened Parkinson’s-like motor and dopamine-system injury in mice. Key Findings Il6 knockout worsened movement: Mice lacking Il6 performed worse after MPTP, a toxin commonly used to model Parkinson’s-like dopamine injury. Female knockout mice showed earlier damage: …

Putamen-Focused tTIS Lowered Parkinson’s Motor Scores

June 12, 2026 by BrainASAP

TL;DR: A 2026 preprint posted to medRxiv found that intermittent theta-burst transcranial temporal interference stimulation (iTBS-tTIS), a noninvasive electrical method aimed at the right putamen, lowered left-sided Parkinson’s motor scores during stimulation in 19 patients. Key Findings 19 Parkinson’s patients and 19 healthy controls completed a randomized, double-blind crossover stimulation study. MDS-UPDRS III, the motor …

+ Load more